Research Update
Esketamine vs Quetiapine in Treatment-Resistant Depression
Ivy Song, MD. Dr. Song has no financial relationships with companies related to this material.
Items Tagged with 'antipsychotics'
ARTICLES
Research Update
How Long to Wait Before Changing Antipsychotics in Schizophrenia?
Lara Tang, MD. Dr. Tang has no financial relationships with companies related to this material.
Research Update
Antipsychotic Dosing: Differences Between Bipolar Mania and Schizophrenia
Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.
Expert Q&A
Treatment Challenges in Atypical Parkinsonism
Alice Flaherty, MD, PhD.
Neurologist, Massachusetts General Hospital; associate professor of neurology and psychiatry, Harvard Medical School, Cambridge, MA.
Dr. Flaherty has no financial relationships with companies related to this material.
Research Update
Antipsychotic Polypharmacy: Maybe Not So Risky After All?
Sébastien Hardy, MD. Dr. Hardy has no financial relationships with companies related to this material.
Clinical Update
Don’t Delay: Interventions in Early Psychosis
Brian Holoyda, MD. Chief Psychiatrist, Contra Costa County Detention Health Services, Martinez, CA. Dr. Holoyda has no financial relationships with companies related to this material.
Research Update
Does Haloperidol Improve Hospitalization or Mortality in Delirium?
Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.
Expert Q&A
Managing Behavioral and Psychological Disturbances in the Nursing Home
Maureen C. Nash, MD.
Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.
Dr. Nash has no financial relationships with companies related to this material.
Expert Q&A
Ethical Principles and Capacity Assessment in Dementia Care
Paul S. Appelbaum, MD
Dollard Professor of Psychiatry, Medicine, & Law; Director, Center for Law, Ethics, and Psychiatry, Columbia University, New York, NY. Co-author of Assessing Competence to Consent to Treatment (Oxford University Press; 1998).
Dr. Appelbaum has no financial relationships with companies related to this material.
Expert Q&A
Lithium, Antidepressants, and Bipolar Disorder
Michael J. Gitlin, MD.
Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).
Dr. Gitlin has no financial relationships with companies related to this material.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
